Dollar For report cites OHSU as an exception among Oregon hospitals that are not meaningfully screening patients for their eligibility for financial assistance, noting that OHSU “has proven that if hospitals take their burden to screen patients seriously they can increase financial assistance without affecting profitability”

A team of OHSU Knight Cancer Institute researchers, led by Jeff Tyner, Ph.D., offers advice on best practices for data collection and analysis to the Portland Police Bureau regarding their stolen vehicle operations. Tyner says: “Police are collecting and using data to make their process more precise and more efficient. That’s exactly the same thing we do here in cancer research."

In a STAT News story about backlash against the Drug Enforcement Administration proposing a new requirement related to prescribing buprenorphine to treat addiction, Ximena Levander, M.D., says, “So at the height of a worsening opioid overdose crisis, to now say patients need to come in person -- I don’t think federal regulators really understand what’s happening on the ground in asking that of patients and providers.”

MIT Technology Review covers a pilot study using mitochondrial replacement therapy for infertility in Greece, revealing six babies born using the technique. In one of the six, carryover maternal mitochondrial DNA had preferentially replicated; Mitalipov says, “We were hoping we wouldn’t see [reversion] in babies. Now we have data to show that this is real -- not just in monkeys but in humans.”

Hello Bio features 10 science conferences to attend in 2023, noting that Ana Quiñones, Ph.D., will be one of the plenary speakers at the Alzheimer’s Association International Conference in July in Amsterdam.

The first cohort of a joint OHSU-St. Charles Health family medicine residency program based in Central Oregon will begin their medical training at OHSU in summer 2024 and arrive in Central Oregon for the remainder of their training in summer 2025. Applications for the program will be accepted in September.

Maria Fleseriu, M.D., is a new member of the Endocrine Society’s Board of Directors.

Rita Parsiani, D.Pharm., is interviewed by KGW about Eli Lilly’s decision to cap the cost of insulin for treatment of diabetes to $35 a month.

Becker’s Spine Review reports that OHSU is among 69 hospitals and health systems nationwide to receive advanced certification for hip and knee replacements from DNV Healthcare.